Newsroom

Check out the latest on our products, technologies, clinical trials, media and more.
Sign-up to receive updates of ImpediMed in the news.

THE PREVENT TRIAL

STOPPING LYMPHEDEMA STARTS WITH PREVENT

Final 3-Year Primary Endpoint Results Published

SEE THE STUDY

ImpediMed in the News

June 17, 2021

Breast cancer patient experiences positive outcome from early surveillance program of lymphedema

KOSA CBS 7, Odessa-Midland, TX

Learn More

March 23, 2021

Dr. David Edmondson discusses Lymphedema and the use of bioimpedance spectroscopy for early detection

WJAR NBC 10 News, Providence, RI

Learn More

December 28, 2020

Technology helps find common complication (lymphedema) after breast surgery, Dr. Hilary Shapiro-Wright, Hamilton Hospital

WKRC CBS Local 12, Hamilton, OH

Learn More

December 28, 2020

Evangelical Community Hospital, Dr. John Turner explains the importance of early detection of lymphedema

WBRE CBS News, Lewisburg, PA

Learn More

ImpediMed Media Kit

Interested in getting support to promote your Lymphedema Prevention Program?
We are here to help. Contact us to access our comprehensive media kit.

Request Media Kit

Newsroom

ImpediMed in the News

Breast cancer patient experiences positive outcome from early surveillance program of lymphedema

Dr. David Edmondson discusses Lymphedema and the use of bioimpedance spectroscopy for early detection

Technology helps find common complication (lymphedema) after breast surgery, Dr. Hilary Shapiro-Wright, Hamilton Hospital

Evangelical Community Hospital, Dr. John Turner explains the importance of early detection of lymphedema

Recent News Releases

New Data Evaluating ImpediMed’s SOZO® in Heart Failure Patients to be Presented at Heart Failure Society of American Annual Scientific Meeting 2022

Why Expanding Access to a Lymphedema Prevention Program is Needed for Cancer Patients

New Bone Data Showing Strong Correlation between ImedpiMed’s SOZO and DXA in Cancer Patients Presented at 39th Annual Miami Breast Cancer Conference

New Bone Data Comparing ImpediMed’s SOZO to DXA in Cancer Patients to be Presented at 39th Annual Miami Breast Cancer Conference

New Data Show Statistically Significant Reduction in Chronic Cancer-Related Lymphedema with Early Detection Using ImpediMed’s L-Dex^® Technology and Intervention

ImpediMed Launches “Lymphedema Can’t” Educational Campaign for Breast Cancer Patients and Survivors

SOZO heart Failure Program Initiated at AdvocateAuroraHealth

HFSA Abstracts Demonstrate the Utility of SOZO for HF Patients

ImpediMed Announces Presentation at Heart Failure Society of America Annual Scientific Meeting That Demonstrates Utility of SOZO^® Digital Health Platform for Heart Failure Patients

FDA Grants Breakthrough Device Designation for ImpediMed’s SOZO^® Digital Health Platform for Renal Failure

ImpediMed Announces Next Generation of SOZO^® Digital Health Platform Software

New Data Show ImpediMed’s Lymphedema Prevention Program Reduces Incidence of Chronic Lymphedema in Breast Cancer Patients and Survivors

ImpediMed Media Kit

Newsroom

ImpediMed in the News

Breast cancer patient experiences positive outcome from early surveillance program of lymphedema

Dr. David Edmondson discusses Lymphedema and the use of bioimpedance spectroscopy for early detection

Technology helps find common complication (lymphedema) after breast surgery, Dr. Hilary Shapiro-Wright, Hamilton Hospital

Evangelical Community Hospital, Dr. John Turner explains the importance of early detection of lymphedema

Recent News Releases

New Data Evaluating ImpediMed’s SOZO® in Heart Failure Patients to be Presented at Heart Failure Society of American Annual Scientific Meeting 2022

Why Expanding Access to a Lymphedema Prevention Program is Needed for Cancer Patients

New Bone Data Showing Strong Correlation between ImedpiMed’s SOZO and DXA in Cancer Patients Presented at 39th Annual Miami Breast Cancer Conference

New Bone Data Comparing ImpediMed’s SOZO to DXA in Cancer Patients to be Presented at 39th Annual Miami Breast Cancer Conference

New Data Show Statistically Significant Reduction in Chronic Cancer-Related Lymphedema with Early Detection Using ImpediMed’s L-Dex® Technology and Intervention

ImpediMed Launches “Lymphedema Can’t” Educational Campaign for Breast Cancer Patients and Survivors

SOZO heart Failure Program Initiated at AdvocateAuroraHealth

HFSA Abstracts Demonstrate the Utility of SOZO for HF Patients

ImpediMed Announces Presentation at Heart Failure Society of America Annual Scientific Meeting That Demonstrates Utility of SOZO® Digital Health Platform for Heart Failure Patients

FDA Grants Breakthrough Device Designation for ImpediMed’s SOZO® Digital Health Platform for Renal Failure

ImpediMed Announces Next Generation of SOZO® Digital Health Platform Software

New Data Show ImpediMed’s Lymphedema Prevention Program Reduces Incidence of Chronic Lymphedema in Breast Cancer Patients and Survivors

ImpediMed Media Kit

New Data Show Statistically Significant Reduction in Chronic Cancer-Related Lymphedema with Early Detection Using ImpediMed’s L-Dex^® Technology and Intervention

ImpediMed Announces Presentation at Heart Failure Society of America Annual Scientific Meeting That Demonstrates Utility of SOZO^® Digital Health Platform for Heart Failure Patients

FDA Grants Breakthrough Device Designation for ImpediMed’s SOZO^® Digital Health Platform for Renal Failure

ImpediMed Announces Next Generation of SOZO^® Digital Health Platform Software